Press Center

Practices
Industries
Jurisdictions
Items
Items
Items

The Middle East as Pharma’s New Mecca: a Closer Look at the UAE and Saudi Arabia

27 August 2026

Russian pharmaceutical manufacturers are increasingly looking toward the GCC and MENA regions. But "entering" and "establishing a foothold" are challenges of entirely different magnitudes.

The two key markets in the region — the UAE and Saudi Arabia — despite their undeniable appeal, require fundamentally different approaches.

Together with the Pharvestnik Magazine, Julia Kuzmenko, Counsel and Head of Regulatory Practice at Lidings, examined the nuances of the regulatory architecture in these two jurisdictions.


Julia Kuzmenko
Counsel

Lidings Launches Regulatory Practice Led by Julia Kuzmenko

18 August 2026

Lidings announces the launch of a new Regulatory Practice. The practice will be headed by the firm's Counsel Julia Kuzmenko.

The creation of the new practice continues the development of Lidings' industry expertise and responds to the growing demand from businesses for comprehensive support amid increasingly complex government regulation and new mandatory requirements.


Julia Kuzmenko
Counsel
Boris Malakhov
Managing Partner

Procedure for Verifying Product Cards on Marketplaces Approved

13 July 2026

On 2 July 2026, the Russian Government published RF Government Resolution No. 821 “On the Procedure for the Verification by the Operator of an Intermediary Digital Platform of the Information Contained in a Product, Work or Service Card Placed on the Intermediary Digital Platform, as Provided for in Clause 1 of Part 1 and Part 2 of Article 7 of the Federal Law ‘On Certain Issues of Regulating the Platform Economy in the Russian Federation’” (hereinafter, the “Resolution No. 821”).

Amendments to Legislation on Control and Supervision Providing for the Immediate Prohibition of the Sale of Products, Including those Subject to Mandatory Labelling

08 July 2026

On 24 June 2026, Draft Law No. 1209354-8 “On Amending Certain Legislative Acts of the Russian Federation” (“Draft Law”) was passed at first reading.

The Draft Law aims to establish a mechanism for control and supervisory authorities to respond promptly to threats to the life and health of citizens arising from the circulation of products, including goods subject to mandatory labelling.

Lidings – Strategic Partner of the Conference on Legal Issues in Pharmaceutical Industry

09 April 2026

April 9th,2026 annual conference Pharmaceuticals – 2026: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.

As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss how the market has changed in 2025 and what awaits us in 2026.

Julia Kuzmenko
Counsel
Boris Malakhov
Managing Partner
Natalya Thotahewage
Counsel